Status:
COMPLETED
Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Solar Lentigines
Eligibility:
All Genders
Up to 80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is a comparison of efficacy and side effects of Q-switched Ruby laser treatment for solar lentigines in two different skin types II and IV.
Detailed Description
It has been widely accepted that dark colored individuals are prone to develop laser induced side effects especially post inflammatory hyperpigmentation(PIH) and it could be a limiting issue in select...
Eligibility Criteria
Inclusion
- Solar Lentigines
- Fitzpatrick skin type II and IV
Exclusion
- Pregnancy
- Age above 80
- Photosensitivity
- Concern for malignancy
- Active Infection
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00386204
Start Date
November 1 2005
End Date
September 1 2006
Last Update
June 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skin Research Center, Shohada-e Tajrish Hospital, Shaheed Beheshti Medical University
Tehran, Tehran Province, Iran, 19899